Sorcs2 Rat 1,2-dichloroethane increases expression ISO Sorcs2 (Mus musculus) 6480464 ethylene dichloride results in increased expression of SORCS2 mRNA CTD PMID:28960355 Sorcs2 Rat 1,2-dimethylhydrazine multiple interactions ISO Sorcs2 (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SORCS2 mRNA CTD PMID:22206623 Sorcs2 Rat 17beta-estradiol multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SORCS2 mRNA CTD PMID:30165855 Sorcs2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Sorcs2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SORCS2 mRNA CTD PMID:19933214 Sorcs2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SORCS2 mRNA CTD PMID:34747641 Sorcs2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Sorcs2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SORCS2 mRNA CTD PMID:26377647 Sorcs2 Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SORCS2 mRNA CTD PMID:32109520 Sorcs2 Rat 3,3',5,5'-tetrabromobisphenol A increases expression ISO Sorcs2 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of SORCS2 mRNA CTD PMID:25172293 Sorcs2 Rat 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of SORCS2 mRNA CTD PMID:23358152 Sorcs2 Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SORCS2 mRNA CTD PMID:28522335 Sorcs2 Rat 4,4'-sulfonyldiphenol increases expression ISO Sorcs2 (Mus musculus) 6480464 bisphenol S results in increased expression of SORCS2 mRNA CTD PMID:30951980 Sorcs2 Rat 4-hydroxyphenyl retinamide increases expression ISO Sorcs2 (Mus musculus) 6480464 Fenretinide results in increased expression of SORCS2 mRNA CTD PMID:28973697 Sorcs2 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SORCS2 mRNA CTD PMID:25825206 Sorcs2 Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SORCS2 mRNA CTD PMID:28959563 Sorcs2 Rat acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SORCS2 mRNA CTD PMID:28959563 Sorcs2 Rat aflatoxin B1 decreases expression ISO SORCS2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of SORCS2 mRNA CTD PMID:22100608|PMID:32234424 Sorcs2 Rat aflatoxin B1 affects methylation ISO SORCS2 (Homo sapiens) 6480464 Aflatoxin B1 affects the methylation of SORCS2 intron CTD PMID:30157460 Sorcs2 Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SORCS2 mRNA CTD PMID:23630614 Sorcs2 Rat Aflatoxin B2 alpha increases methylation ISO SORCS2 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of SORCS2 intron CTD PMID:30157460 Sorcs2 Rat all-trans-retinoic acid increases expression ISO SORCS2 (Homo sapiens) 6480464 Tretinoin results in increased expression of SORCS2 mRNA CTD PMID:23724009 Sorcs2 Rat aristolochic acid A decreases expression ISO SORCS2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SORCS2 mRNA CTD PMID:33212167 Sorcs2 Rat arsane affects methylation ISO SORCS2 (Homo sapiens) 6480464 Arsenic affects the methylation of SORCS2 gene CTD PMID:25304211 Sorcs2 Rat arsane decreases expression ISO Sorcs2 (Mus musculus) 6480464 Arsenic results in decreased expression of SORCS2 mRNA CTD PMID:38150313 Sorcs2 Rat arsenic atom affects methylation ISO SORCS2 (Homo sapiens) 6480464 Arsenic affects the methylation of SORCS2 gene CTD PMID:25304211 Sorcs2 Rat arsenic atom decreases expression ISO Sorcs2 (Mus musculus) 6480464 Arsenic results in decreased expression of SORCS2 mRNA CTD PMID:38150313 Sorcs2 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SORCS2 gene CTD PMID:28931070 Sorcs2 Rat benzene-1,2,4-triol decreases expression ISO SORCS2 (Homo sapiens) 6480464 hydroxyhydroquinone results in decreased expression of SORCS2 mRNA CTD PMID:39245080 Sorcs2 Rat benzo[a]pyrene decreases expression ISO SORCS2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SORCS2 mRNA CTD PMID:21871943 Sorcs2 Rat benzo[a]pyrene affects methylation ISO SORCS2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SORCS2 intron; Benzo(a)pyrene affects the methylation of SORCS2 promoter CTD PMID:27901495|PMID:30157460 Sorcs2 Rat benzo[a]pyrene decreases expression ISO Sorcs2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SORCS2 mRNA CTD PMID:20713471|PMID:22228805 Sorcs2 Rat benzo[b]fluoranthene increases expression ISO Sorcs2 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of SORCS2 mRNA CTD PMID:26377693 Sorcs2 Rat benzo[e]pyrene affects methylation ISO SORCS2 (Homo sapiens) 6480464 benzo(e)pyrene affects the methylation of SORCS2 intron CTD PMID:30157460 Sorcs2 Rat benzo[e]pyrene increases methylation ISO SORCS2 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of SORCS2 exon CTD PMID:30157460 Sorcs2 Rat beta-lapachone decreases expression ISO SORCS2 (Homo sapiens) 6480464 beta-lapachone results in decreased expression of SORCS2 mRNA CTD PMID:38218311 Sorcs2 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SORCS2 mRNA CTD PMID:25181051 Sorcs2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SORCS2 mRNA CTD PMID:41034487 Sorcs2 Rat bisphenol A decreases methylation ISO SORCS2 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of SORCS2 gene CTD PMID:31601247 Sorcs2 Rat bisphenol A multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of SORCS2 gene CTD PMID:31601247 Sorcs2 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SORCS2 gene CTD PMID:28505145 Sorcs2 Rat bisphenol A increases expression ISO Sorcs2 (Mus musculus) 6480464 bisphenol A results in increased expression of SORCS2 mRNA CTD PMID:25594700|PMID:35479511 Sorcs2 Rat Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of SORCS2 protein CTD PMID:28903499 Sorcs2 Rat butane-2,3-dione decreases expression ISO SORCS2 (Homo sapiens) 6480464 Diacetyl results in decreased expression of SORCS2 mRNA CTD PMID:30710127 Sorcs2 Rat Butylbenzyl phthalate increases methylation ISO Sorcs2 (Mus musculus) 6480464 butylbenzyl phthalate results in increased methylation of SORCS2 intron CTD PMID:28392331 Sorcs2 Rat cantharidin decreases expression ISO Sorcs2 (Mus musculus) 6480464 Cantharidin results in decreased expression of SORCS2 mRNA CTD PMID:36907384 Sorcs2 Rat carbon nanotube increases expression ISO Sorcs2 (Mus musculus) 6480464 Nanotubes, Carbon analog results in increased expression of SORCS2 mRNA; Nanotubes, Carbon results in increased more ... CTD PMID:25554681 Sorcs2 Rat CGP 52608 multiple interactions ISO SORCS2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SORCS2 gene] CTD PMID:28238834 Sorcs2 Rat choline multiple interactions ISO Sorcs2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... CTD PMID:20938992 Sorcs2 Rat cyclosporin A decreases methylation ISO SORCS2 (Homo sapiens) 6480464 Cyclosporine results in decreased methylation of SORCS2 promoter CTD PMID:27989131 Sorcs2 Rat decabromodiphenyl ether multiple interactions EXP 6480464 [Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in more ... CTD PMID:32207525 Sorcs2 Rat dorsomorphin multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Sorcs2 Rat doxorubicin affects methylation EXP 6480464 Doxorubicin affects the methylation of SORCS2 gene CTD PMID:28962528 Sorcs2 Rat doxorubicin decreases expression ISO Sorcs2 (Mus musculus) 6480464 Doxorubicin results in decreased expression of SORCS2 mRNA CTD PMID:39631538 Sorcs2 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SORCS2 mRNA CTD PMID:29391264 Sorcs2 Rat ethanol increases expression ISO Sorcs2 (Mus musculus) 6480464 Ethanol results in increased expression of SORCS2 mRNA CTD PMID:30319688 Sorcs2 Rat ethyl methanesulfonate increases expression ISO SORCS2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of SORCS2 mRNA CTD PMID:23649840 Sorcs2 Rat fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of SORCS2 mRNA CTD PMID:30307764 Sorcs2 Rat folic acid multiple interactions ISO Sorcs2 (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SORCS2 mRNA; [Methionine deficiency co-treated more ... CTD PMID:20938992|PMID:22206623 Sorcs2 Rat folic acid decreases expression ISO Sorcs2 (Mus musculus) 6480464 Folic Acid results in decreased expression of SORCS2 mRNA CTD PMID:25629700 Sorcs2 Rat formaldehyde increases expression ISO SORCS2 (Homo sapiens) 6480464 Formaldehyde results in increased expression of SORCS2 mRNA CTD PMID:23649840 Sorcs2 Rat fulvestrant multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of SORCS2 gene CTD PMID:31601247 Sorcs2 Rat furan increases expression EXP 6480464 furan results in increased expression of SORCS2 mRNA CTD PMID:27387713 Sorcs2 Rat genistein decreases expression ISO Sorcs2 (Mus musculus) 6480464 Genistein results in decreased expression of SORCS2 mRNA CTD PMID:32186404 Sorcs2 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SORCS2 mRNA CTD PMID:33387578 Sorcs2 Rat glyphosate affects methylation EXP 6480464 Glyphosate affects the methylation of SORCS2 gene CTD PMID:35440735 Sorcs2 Rat hydrogen peroxide affects expression ISO SORCS2 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SORCS2 mRNA CTD PMID:20044591 Sorcs2 Rat iron dichloride decreases expression ISO SORCS2 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of SORCS2 mRNA CTD PMID:35984750 Sorcs2 Rat isoprenaline decreases expression ISO Sorcs2 (Mus musculus) 6480464 Isoproterenol results in decreased expression of SORCS2 mRNA CTD PMID:20003209 Sorcs2 Rat L-methionine multiple interactions ISO Sorcs2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... CTD PMID:20938992 Sorcs2 Rat lead diacetate multiple interactions ISO Sorcs2 (Mus musculus) 6480464 [lead acetate results in increased abundance of Lead] which results in increased methylation of SORCS2 more ... CTD PMID:33445541 Sorcs2 Rat lead(0) affects expression ISO SORCS2 (Homo sapiens) 6480464 Lead affects the expression of SORCS2 mRNA CTD PMID:28903495 Sorcs2 Rat lead(0) multiple interactions ISO Sorcs2 (Mus musculus) 6480464 [lead acetate results in increased abundance of Lead] which results in increased methylation of SORCS2 more ... CTD PMID:33445541 Sorcs2 Rat manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of SORCS2 mRNA CTD PMID:28801915 Sorcs2 Rat mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of SORCS2 mRNA CTD PMID:23358152 Sorcs2 Rat methapyrilene affects methylation ISO SORCS2 (Homo sapiens) 6480464 Methapyrilene affects the methylation of SORCS2 intron CTD PMID:30157460 Sorcs2 Rat methapyrilene increases methylation ISO SORCS2 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of SORCS2 exon CTD PMID:30157460 Sorcs2 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SORCS2 gene CTD PMID:35440735 Sorcs2 Rat methyl methanesulfonate increases expression ISO SORCS2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of SORCS2 mRNA CTD PMID:23649840 Sorcs2 Rat methylmercury chloride decreases expression ISO SORCS2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SORCS2 mRNA CTD PMID:28001369 Sorcs2 Rat okadaic acid decreases expression ISO SORCS2 (Homo sapiens) 6480464 Okadaic Acid results in decreased expression of SORCS2 mRNA CTD PMID:38832940 Sorcs2 Rat ozone multiple interactions ISO Sorcs2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ... CTD PMID:34911549 Sorcs2 Rat panobinostat multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Sorcs2 Rat panobinostat decreases expression ISO SORCS2 (Homo sapiens) 6480464 panobinostat results in decreased expression of SORCS2 mRNA CTD PMID:26272509 Sorcs2 Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SORCS2 mRNA CTD PMID:32680482 Sorcs2 Rat pentane-2,3-dione decreases expression ISO SORCS2 (Homo sapiens) 6480464 2,3-pentanedione results in decreased expression of SORCS2 mRNA CTD PMID:30710127 Sorcs2 Rat phenylmercury acetate decreases expression ISO SORCS2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of SORCS2 mRNA CTD PMID:26272509 Sorcs2 Rat phenylmercury acetate multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Sorcs2 Rat purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of SORCS2 mRNA CTD PMID:23358152 Sorcs2 Rat SB 431542 multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Sorcs2 Rat sodium arsenite increases expression ISO SORCS2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SORCS2 mRNA; sodium arsenite results in increased expression more ... CTD PMID:38228842|PMID:38568856 Sorcs2 Rat sulforaphane decreases expression ISO SORCS2 (Homo sapiens) 6480464 sulforaphane results in decreased expression of SORCS2 mRNA CTD PMID:31838189 Sorcs2 Rat sunitinib decreases expression ISO SORCS2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of SORCS2 mRNA CTD PMID:31533062 Sorcs2 Rat testosterone increases expression ISO SORCS2 (Homo sapiens) 6480464 Testosterone results in increased expression of SORCS2 mRNA CTD PMID:33359661 Sorcs2 Rat titanium dioxide increases expression ISO Sorcs2 (Mus musculus) 6480464 titanium dioxide results in increased expression of SORCS2 mRNA CTD PMID:23557971|PMID:27760801 Sorcs2 Rat titanium dioxide increases methylation ISO Sorcs2 (Mus musculus) 6480464 titanium dioxide results in increased methylation of SORCS2 promoter CTD PMID:35295148 Sorcs2 Rat titanium dioxide decreases methylation ISO Sorcs2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of SORCS2 gene CTD PMID:35295148 Sorcs2 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SORCS2 mRNA CTD PMID:33387578 Sorcs2 Rat trichostatin A decreases expression ISO SORCS2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of SORCS2 mRNA CTD PMID:24935251|PMID:26272509 Sorcs2 Rat trichostatin A multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Sorcs2 Rat triclosan increases expression ISO SORCS2 (Homo sapiens) 6480464 Triclosan results in increased expression of SORCS2 mRNA CTD PMID:30510588 Sorcs2 Rat tungsten decreases expression ISO Sorcs2 (Mus musculus) 6480464 Tungsten results in decreased expression of SORCS2 mRNA CTD PMID:30912803 Sorcs2 Rat urethane decreases expression ISO SORCS2 (Homo sapiens) 6480464 Urethane results in decreased expression of SORCS2 mRNA CTD PMID:28818685 Sorcs2 Rat valproic acid decreases expression ISO SORCS2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SORCS2 mRNA CTD PMID:23179753|PMID:24383497|PMID:28001369|PMID:29154799 Sorcs2 Rat valproic acid affects expression ISO SORCS2 (Homo sapiens) 6480464 Valproic Acid affects the expression of SORCS2 mRNA CTD PMID:25979313 Sorcs2 Rat valproic acid multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Sorcs2 Rat vorinostat multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386